Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$267M |
| 2 |
Home Depot
HD
|
+$252M |
| 3 |
Northrop Grumman
NOC
|
+$221M |
| 4 |
Gilead Sciences
GILD
|
+$175M |
| 5 |
Dollar General
DG
|
+$137M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HP
HPQ
|
+$287M |
| 2 |
TWTR
Twitter, Inc.
TWTR
|
+$278M |
| 3 |
Biogen
BIIB
|
+$244M |
| 4 |
iShares Russell 3000 ETF
IWV
|
+$198M |
| 5 |
Exelon
EXC
|
+$185M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.43% |
| 2 | Financials | 14.36% |
| 3 | Healthcare | 13.9% |
| 4 | Consumer Discretionary | 13.25% |
| 5 | Industrials | 11.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
Wyndham Hotels & Resorts
WH
$5.52B
| $680K | ﹤0.01% |
10,821
+4,265
| +65% | +$237K |
|
1652
Rayonier
RYN
$6.31B
| $679K | ﹤0.01% |
22,849
-1,411
| -6% | -$38.4K |
|
1653
Forrester Research
FORR
$228M
| $678K | ﹤0.01% |
16,256
+5,785
| +55% | +$216K |
|
1654
HubSpot
HUBS
$12.2B
| $671K | ﹤0.01% |
4,234
-3,723
| -47% | -$570K |
|
1655
Coherus Oncology
CHRS
$210M
| $670K | ﹤0.01% |
37,185
+19,254
| +107% | +$355K |
|
1656
MGE Energy Inc
MGEE
$3B
| $670K | ﹤0.01% |
8,503
-4,048
| -32% | -$312K |
|
1657
Interface
TILE
$2.21B
| $670K | ﹤0.01% |
+40,376
| New | +$650K |
|
1658
Peoples Bancorp
PEBO
$1.43B
| $665K | ﹤0.01% |
+19,184
| New | +$628K |
|
1659
Inspire Medical Systems
INSP
$1.78B
| $663K | ﹤0.01% |
8,930
-10
| -0.1% | -$643 |
|
1660
Byline Bancorp
BY
$1.73B
| $662K | ﹤0.01% |
+33,812
| New | +$618K |
|
1661
Knowles
KN
$2.78B
| $662K | ﹤0.01% |
31,313
-353
| -1% | -$7.58K |
|
1662
Mistras Group
MG
$608M
| $662K | ﹤0.01% |
+46,396
| New | +$656K |
|
1663
Simpson Manufacturing
SSD
$7.69B
| $661K | ﹤0.01% |
8,244
-970
| -11% | -$75.6K |
|
1664
Standard BioTools
LAB
$255M
| $660K | ﹤0.01% |
189,798
-74,650
| -28% | -$263K |
|
|
HAPN
1665
Happen Inc
HAPN
$2.11B
| $656K | ﹤0.01% |
52,017
-11,039
| -18% | -$142K |
|
|
FMBI
1666
DELISTED
First Midwest Bancorp Inc/IL
FMBI
| $654K | ﹤0.01% |
28,348
+12,498
| +79% | +$266K |
|
1667
International Seaways
INSW
$4.95B
| $652K | ﹤0.01% |
21,892
+3,705
| +20% | +$96.5K |
|
|
HIBB
1668
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $646K | ﹤0.01% |
23,049
+8,060
| +54% | +$204K |
|
1669
RadNet
RDNT
$5.88B
| $639K | ﹤0.01% |
31,467
-16,831
| -35% | -$289K |
|
1670
Artisan Partners
APAM
$3.05B
| $638K | ﹤0.01% |
19,751
+8,753
| +80% | +$253K |
|
1671
Chesapeake Utilities
CPK
$3.26B
| $637K | ﹤0.01% |
6,643
-4,618
| -41% | -$429K |
|
1672
Companhia Siderúrgica Nacional
SID
$1.37B
| $636K | ﹤0.01% |
184,236
-57,475
| -24% | -$179K |
|
|
APLS
1673
DELISTED
Apellis Pharmaceuticals
APLS
| $631K | ﹤0.01% |
+20,620
| New | +$571K |
|
1674
Malibu Boats
MBUU
$579M
| $630K | ﹤0.01% |
15,378
+6,459
| +72% | +$233K |
|
1675
Stock Yards Bancorp
SYBT
$2.54B
| $630K | ﹤0.01% |
15,348
+1,330
| +9% | +$52.8K |
|
Similar funds
Cliff Asness's Q4 2019 Portfolio in Review
As of Q4 2019, Cliff Asness held 2,253 positions worth $88B, up 3.6% from $84.9B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Cliff Asness withdrew a net $3.28B in Q4 2019, closing 142 positions and reducing 1,092 holdings. Its most notable exit was iShares Russell 3000 ETF, an estimated $198M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Cliff Asness opened a new position in DaVita worth $31.1M.
- Cliff Asness's largest Q4 2019 buy was DaVita: 417,883 shares worth $31.1M.
- Cliff Asness added most to Humana in Q4 2019, an estimated $267M increase.
- Cliff Asness's biggest Q4 2019 reduction was HP, cutting an estimated $287M.
- Cliff Asness fully exited iShares Russell 3000 ETF in Q4 2019, selling an estimated $198M.
- Cliff Asness's ten largest holdings make up 13% of its $88B portfolio in Q4 2019.
- Cliff Asness opened 146 new positions and closed 142 in Q4 2019.
- Cliff Asness's portfolio value rose 3.6% quarter-over-quarter to $88B.
Based on AQR Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.